Eczema, asthma, and sinusitis are all common inflammatory skin diseases that together affect more than 50 million Americans. Though these conditions can manifest in different ways for different people, they all share the same root causes. In each case, it’s an overactive immune response that leads to excessive inflammation and the resulting skin rashes or mucous production.
All three of these conditions are currently unmet medical needs – there is no specific treatment or cure available outside of managing their symptoms with other drugs.
The need to find new solutions is urgent given the significant burden they pose on patients and healthcare systems at large. It is in this context that Dupixent has emerged as a promising treatment option for patients suffering from eczema, asthma, and sinusitis.
Who Makes the Decision to Use Dupixent?
The decision to use Dupixent will be made by the doctor in accordance with your specific symptoms and condition. It is important to note that Dupixent is not a cure for eczema, asthma, or sinusitis. Its role is to manage symptoms and reduce the frequency of flare-ups.
This decision is usually made after considering the benefits and risks associated with the available alternatives. This is important as there might be situations in which one or another would be more appropriate. For example, if your eczema symptoms are limited to your hands and feet, Dupixent would not be the best option.
What is Dupixent and How Does it Work?
Dupixent (Crisaborole) is a targeted biologic therapy approved to treat moderate-to-severe eczema in people aged 12 years and older, who are uncontrolled by topical treatments and who have failed to respond to other systemic therapies. It is also approved for treating people 12 years and older with moderate to severe asthma. Dupixent works by targeting IL-4/IL-13 pathways, thereby suppressing the immune response and reducing inflammation. It is delivered via an injection every 2 or 4 weeks.
The most common side effects of Dupixent include injection site reactions, headache, and upper respiratory infections. Dupixent has a boxed warning regarding the increased risk of serious infections. Infections may be life threatening and may require hospitalization. The risk of infection is highest during the first two months of therapy.
Where Can You Get Dupixent?
Dupixent is a prescription drug. As such, it can only be obtained by prescription. That means you will have to visit your doctor so that they can assess your condition and write you a prescription if Dupixent is a viable option for you.
Final Words: Dupixent: Is it Worth Trying?
Dupixent is a promising new treatment option for patients suffering from eczema, asthma, and sinusitis. It works by targeting IL-4/IL-13 pathways, thereby suppressing the immune response and reducing inflammation. Dupixent is a biologic drug that should be delivered by a doctor. That means it requires a prescription. It is important to note that Dupixent is not a cure for eczema, asthma, or sinusitis. Its role is to manage symptoms and reduce the frequency of flare-ups.